Sock maker Bombas is the latest company preparing to ride the ESG investing wave, with the certified B Corp reportedly considering an IPO as soon as this year. It would join Greek yogurt brand Chobani (CHO) in the IPO pipeline...read more
One biotech and three SPACs went public this past week as the IPO market shows more signs of opening up. The VIX volatility index is hovering around 30, the IPO index is now up 58% from its March lows, and eight companies submitted initial filings, the most...read more
Novus Capital Corp, a blank check company targeting the smart technology innovations market, raised $100 million by offering 10 million units at $10. Units consist of one share of common stock and one warrant exercisable at $11.50. The Indianapolis, IN-based...read more
Lyra Therapeutics (LYRA) popped 16% in its IPO this past week, the latest biotech to surge in its public debut. It was joined by three SPACs, continuing an uptick in blank check activity. Despite enduring ...read more
The IPO market's ESG craze set to continue with socks and Greek yogurt
Sock maker Bombas is the latest company preparing to ride the ESG investing wave, with the certified B Corp reportedly considering an IPO as soon as this year. It would join Greek yogurt brand Chobani (CHO) in the IPO pipeline...read more
US IPO Weekly Recap: Filing activity pops in a 1 IPO week
One biotech and three SPACs went public this past week as the IPO market shows more signs of opening up. The VIX volatility index is hovering around 30, the IPO index is now up 58% from its March lows, and eight companies submitted initial filings, the most...read more
Smart tech SPAC Novus Capital Corp prices $100 million IPO at $10
Novus Capital Corp, a blank check company targeting the smart technology innovations market, raised $100 million by offering 10 million units at $10. Units consist of one share of common stock and one warrant exercisable at $11.50. The Indianapolis, IN-based...read more
US IPO Weekly Recap: Biotech hot streak continues amid another wave of SPACs
Lyra Therapeutics (LYRA) popped 16% in its IPO this past week, the latest biotech to surge in its public debut. It was joined by three SPACs, continuing an uptick in blank check activity. Despite enduring ...read more